We are thrilled to share exciting news from ourMargaret West Comprehensive Breast Center and its Director, Dr. Richard Fine. The FDA has granted marketing authorization for ProSense® cryoablation, a minimally invasive, outpatient treatment option for select patients with early-stage, low-risk breast cancer. This groundbreaking decision was supported by data from the pivotal ICE3 clinical trial, for which Dr. Fine served… Read more »